Home LiteratureArticle Details
PMID: 19344420 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Replicative potential of human natural killer cells.

British journal of haematology ·Vol. 145 ·No. 5 ·2009-06-00 ·Pages 606-13

Fujisaki H, Kakuda H, Imai C, Mullighan CG, Campana D

Abstract

The replicative potential of human CD56(+) CD3(-) natural killer (NK) cells is unknown. We found that by exposing NK cells to the leukaemic cell line K562 genetically modified to express 4-1BB ligand and interleukin 15 (K562-mb15-41BBL), they expanded for up to 30 population doublings, achieving numbers that ranged from 1.6 x 10(5) to 1.2 x 10(11)% (median, 5.9 x 10(6)%; n = 7) of those originally seeded. However, NK cells eventually became unresponsive to stimulation and died. Their demise could be suppressed by enforcing the expression of the human telomerase reverse transcriptase gene (TERT). TERT-overexpressing NK cells continued to proliferate in response to K562-mb15-41BBL stimulation for more than 1 year of culture, while maintaining a normal karyotype and genotype. Long-lived NK cells had high cytotoxicity against myeloid and T-lineage leukaemic cells. They remained susceptible to genetic manipulation, becoming highly cytotoxic to B-lineage leukaemic cells after expression of anti-CD19 signaling receptors. Thus, human NK cells have a replicative potential similar to that of T lymphocytes and their lifespan can be significantly prolonged by an increase in TERT activity. We suggest that the methods described here should have many applications in studies of NK cell biology and NK cell-based therapies.

MeSH Terms
4-1BB Ligand/metabolism Adult Cell Line, Transformed Cell Line, Tumor Cell Proliferation Cells, Cultured Chromosome Aberrations Cytotoxicity Tests, Immunologic Flow Cytometry Humans Immunophenotyping Interleukin-15/metabolism Karyotyping Killer Cells, Natural/cytology,immunology,physiology Polymorphism, Single Nucleotide Telomerase/metabolism
Chemicals
4-1BB Ligand Interleukin-15 TERT protein, human Telomerase
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Fujisaki Hiroyuki
Department of Oncology, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis TN 38105, USA.
Kakuda Harumi
Imai Chihaya
Mullighan Charles G
Campana Dario
References (30)
30 references, click to expand
  1. Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT.
    Blood. 2005 Jul 1;106(1):43-50 PMID: 15741219
  2. Natural killer cells: diversity in search of a niche.
    Nat Immunol. 2008 May;9(5):473-5 PMID: 18425102
  3. A potential role for interleukin-15 in the regulation of human natural killer cell survival.
    J Clin Invest. 1997 Mar 1;99(5):937-43 PMID: 9062351
  4. Transfer of the human telomerase reverse transcriptase (TERT) gene into T lymphocytes results in extension of replicative potential.
    Blood. 2001 Aug 1;98(3):597-603 PMID: 11468156
  5. Natural killer cell-directed therapies: moving from unexpected results to successful strategies.
    Nat Immunol. 2008 May;9(5):486-94 PMID: 18425105
  6. Circular binary segmentation for the analysis of array-based DNA copy number data.
    Biostatistics. 2004 Oct;5(4):557-72 PMID: 15475419
  7. Functions of natural killer cells.
    Nat Immunol. 2008 May;9(5):503-10 PMID: 18425107
  8. Response of resting human peripheral blood natural killer cells to interleukin 2.
    J Exp Med. 1984 Oct 1;160(4):1147-69 PMID: 6434688
  9. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype.
    Eur J Immunol. 1975 Feb;5(2):112-7 PMID: 1234049
  10. Immortalization of human CD8+ T cell clones by ectopic expression of telomerase reverse transcriptase.
    J Immunol. 2000 Oct 15;165(8):4239-45 PMID: 11035057
  11. Unravelling natural killer cell function: triggering and inhibitory human NK receptors.
    EMBO J. 2004 Jan 28;23(2):255-9 PMID: 14685277
  12. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells.
    J Immunol. 1992 Apr 15;148(8):2429-36 PMID: 1373169
  13. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
    Nat Immun. 1996-1997;15(5):213-26 PMID: 9390270
  14. Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation.
    Leukemia. 2004 Nov;18(11):1835-8 PMID: 15457184
  15. Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect.
    Blood. 2002 Sep 15;100(6):1935-47 PMID: 12200350
  16. Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.
    Leukemia. 2003 Oct;17(10):1973-80 PMID: 14513047
  17. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines.
    Nat Immun Cell Growth Regul. 1987;6(4):171-88 PMID: 2960890
  18. Role of monocytes in the expansion of human activated natural killer cells.
    Blood. 1992 Nov 1;80(9):2221-9 PMID: 1421393
  19. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
    J Immunol. 2007 Nov 1;179(9):5977-89 PMID: 17947671
  20. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.
    Nature. 2007 Apr 12;446(7137):758-64 PMID: 17344859
  21. A model for the differentiation of human natural killer cells. Studies on the in vitro activation of Leu-11+ granular lymphocytes with a natural killer-sensitive tumor cell, K562.
    J Exp Med. 1985 Jun 1;161(6):1464-82 PMID: 3159818
  22. NK cell recognition.
    Annu Rev Immunol. 2005;23:225-74 PMID: 15771571
  23. Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion?
    Immunol Today. 1997 Sep;18(9):450-4 PMID: 9293162
  24. Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia.
    Leukemia. 2004 Apr;18(4):676-84 PMID: 14961035
  25. Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells.
    Blood. 2005 Jul 1;106(1):376-83 PMID: 15755898
  26. Selective expansion of human natural killer cells from peripheral blood mononuclear cells by the cell line, HFWT.
    Jpn J Cancer Res. 2002 Mar;93(3):313-9 PMID: 11927014
  27. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.
    Blood. 2005 Apr 15;105(8):3051-7 PMID: 15632206
  28. Ectopic hTERT expression extends the life span of human CD4+ helper and regulatory T-cell clones and confers resistance to oxidative stress-induced apoptosis.
    Blood. 2003 Jun 1;101(11):4512-9 PMID: 12586632
  29. NK cell receptors and their ligands in leukemia.
    Leukemia. 2008 Feb;22(2):249-57 PMID: 18046448
  30. Growth factors from murine sarcoma virus-transformed cells.
    Proc Natl Acad Sci U S A. 1978 Aug;75(8):4001-5 PMID: 211512
Article Info
Journal
British journal of haematology
Abbr.
Br J Haematol
ISSN
1365-2141
Published
2009-06-00
Epub
2009-00-26
Pages
606-13
Language
English
Region
England
NLM ID
0372544
PMCID
PMC2776622
Subset
IM
Grants
NCI NIH HHS · R01 CA113482-04 · United States
NCI NIH HHS · CA 113482 · United States
NCI NIH HHS · P30 CA021765 · United States
NCI NIH HHS · R01 CA113482 · United States
NCI NIH HHS · CA 21765 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com